Psychiatric Times articleshttps://www.psychiatrictimes.com/newsPsychiatric Times articles© 2026 MJH Life Sciences™ and Psychiatric Times. All rights reserved.Wed, 15 Apr 2026 01:26:27 +00005en-us14447https://www.psychiatrictimes.com/newshttps://www.psychiatrictimes.com/logo.webphttps://www.psychiatrictimes.com/view/study-links-autism-and-alzheimer-disease-through-shared-pathophysiologyhttps://www.psychiatrictimes.com/view/study-links-autism-and-alzheimer-disease-through-shared-pathophysiology<![CDATA[Shared pathophysiology between Alzheimer disease and autism may expand diagnosis and treatment opportunities.]]>Tue, 14 Apr 2026 19:09:56 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/new-us-grant-program-announced-for-post-approval-comp360-provider-traininghttps://www.psychiatrictimes.com/view/new-us-grant-program-announced-for-post-approval-comp360-provider-training<![CDATA[A new US-based grant program seeks to create training content for health care providers who want to be able to deliver investigational COMP360 psilocybin treatment. ]]>Tue, 14 Apr 2026 19:00:20 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/the-curious-story-of-sigma-1-receptorshttps://www.psychiatrictimes.com/view/the-curious-story-of-sigma-1-receptors<![CDATA[Explore how sigma‑1 receptors shape ER–mitochondria signaling, calm neuroinflammation, and inspire therapies from fluvoxamine to dextromethorphan.]]>Tue, 14 Apr 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/lybalvi-associated-with-improvement-in-negative-symptoms-of-schizophrenia-findings-from-long-term-analysishttps://www.psychiatrictimes.com/view/lybalvi-associated-with-improvement-in-negative-symptoms-of-schizophrenia-findings-from-long-term-analysis<![CDATA[]]>Tue, 14 Apr 2026 14:32:14 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/clinician-competence-in-the-age-of-chatbotshttps://www.psychiatrictimes.com/view/clinician-competence-in-the-age-of-chatbots<![CDATA[Psychiatry training must catch up with chatbot literacy, intake, safety, ethics, and supervised AI integration.]]>Tue, 14 Apr 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/earth-is-a-lifeboat-and-we-in-psychiatry-can-be-lifeguardshttps://www.psychiatrictimes.com/view/earth-is-a-lifeboat-and-we-in-psychiatry-can-be-lifeguards<![CDATA[With Artemis II’s journey in mind, a psychiatrist urges mental health action on climate denial, resilience, and saving Earth before it’s too late.]]>Tue, 14 Apr 2026 13:15:15 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/insights-in-treating-anxiety-and-the-pharmaceutical-perspectivehttps://www.psychiatrictimes.com/view/insights-in-treating-anxiety-and-the-pharmaceutical-perspective<![CDATA[A pharma expert and clinician shares perspectives on developing treatments.]]>Tue, 14 Apr 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/meeting-the-unique-needs-of-youth-with-substance-use-disorder-new-asam-guidelineshttps://www.psychiatrictimes.com/view/meeting-the-unique-needs-of-youth-with-substance-use-disorder-new-asam-guidelines<![CDATA[New youth-focused substance use guidelines spotlight prevention, brain development, and coordinated mental health support to improve outcomes early.]]>Mon, 13 Apr 2026 18:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/bits-and-pieces-building-a-family-on-3-continents-a-story-of-italian-migrationhttps://www.psychiatrictimes.com/view/bits-and-pieces-building-a-family-on-3-continents-a-story-of-italian-migration<![CDATA[“Each person the right to tell their own story in their own way”: An Italian-Canadian psychiatrist traces family journeys across 3 countries, revealing migration’s lessons on identity, belonging, and resilience.]]>Mon, 13 Apr 2026 16:56:29 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/spring-into-action-the-importance-of-physical-activityhttps://www.psychiatrictimes.com/view/spring-into-action-the-importance-of-physical-activity<![CDATA[Exercise boosts recovery in depression and psychosis, and improves cognition and quality of life; clinicians can now use the 5A model to make movement a routine psychiatric tool.]]>Mon, 13 Apr 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/finding-joy-in-the-artemis-ii-astronauts-and-in-psychiatryhttps://www.psychiatrictimes.com/view/finding-joy-in-the-artemis-ii-astronauts-and-in-psychiatry<![CDATA[Artemis II astronauts spark a psychiatrist’s look at “joy trains,” music, and meaning—practical ways teams rekindle joy and prevent burnout.]]>Mon, 13 Apr 2026 13:12:28 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/a-new-reality-for-psychiatry-is-reality-tv-a-friend-or-foehttps://www.psychiatrictimes.com/view/a-new-reality-for-psychiatry-is-reality-tv-a-friend-or-foe<![CDATA[Reality TV puts therapy on camera, reducing stigma but raising ethical, privacy, and misinformation risks—and affecting viewers and cast.]]>Fri, 10 Apr 2026 16:00:43 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/new-adolescent-substance-use-disorder-guidelines-reducing-patient-and-family-burdenhttps://www.psychiatrictimes.com/view/new-adolescent-substance-use-disorder-guidelines-reducing-patient-and-family-burden<![CDATA[New ASAM youth criteria redefine SUD care with brain-stage levels, chronic monitoring, detox safety, and family-centered support.]]>Fri, 10 Apr 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/i-want-to-read-at-the-white-house-poemhttps://www.psychiatrictimes.com/view/i-want-to-read-at-the-white-house-poem<![CDATA["I want to read poems at the white house. I want to read poems at the white house with all the pomp available." ]]>Fri, 10 Apr 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/the-challenges-for-reentry-of-the-artemis-ii-astronauts-and-ourselveshttps://www.psychiatrictimes.com/view/the-challenges-for-reentry-of-the-artemis-ii-astronauts-and-ourselves<![CDATA[From Artemis II’s fiery return to life after prison or vacation, this article shows how reentry stress becomes a skill for growth.]]>Fri, 10 Apr 2026 13:23:11 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/developments-in-donanemab-with-brandy-matthews-mdhttps://www.psychiatrictimes.com/view/developments-in-donanemab-with-brandy-matthews-md<![CDATA[New data on long-term donanemab treatment. ]]>Fri, 10 Apr 2026 12:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/improving-care-for-lgbtq-and-immigrant-patientshttps://www.psychiatrictimes.com/view/improving-care-for-lgbtq-and-immigrant-patients<![CDATA[Learn more about how to support LGBTQ+ and immigrant patients.]]>Fri, 10 Apr 2026 11:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/when-pills-are-not-the-answer-rethinking-the-psychiatrists-scripthttps://www.psychiatrictimes.com/view/when-pills-are-not-the-answer-rethinking-the-psychiatrists-script<![CDATA[To prescribe or not to prescribe? ]]>Thu, 09 Apr 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/deep-intracranial-frequency-stimulation-reduces-self-injury-and-depression-symptoms-in-female-adolescentshttps://www.psychiatrictimes.com/view/deep-intracranial-frequency-stimulation-reduces-self-injury-and-depression-symptoms-in-female-adolescents<![CDATA[Deep intracranial frequency stimulation 77.5 Hz high-gamma approach was associated with statistically significant reductions in self-injury behaviors and depressive symptoms in female adolescents with nonsuicidal self-injury.]]>Thu, 09 Apr 2026 14:28:36 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/biomarker-testing-for-alzheimer-disease-and-latest-developmentshttps://www.psychiatrictimes.com/view/biomarker-testing-for-alzheimer-disease-and-latest-developments<![CDATA[Blood-based biomarkers for Alzheimer disease continue to improve, shares expert researcher. ]]>Thu, 09 Apr 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/the-outer-space-astronauts-of-artemis-ii-are-also-piloting-us-to-inner-spacehttps://www.psychiatrictimes.com/view/the-outer-space-astronauts-of-artemis-ii-are-also-piloting-us-to-inner-space<![CDATA[What can the Artemis II astronauts tell us about both outer space and the inner space of our minds? ]]>Thu, 09 Apr 2026 13:18:16 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/apa-preview-social-worldview-of-psychiatry-and-societyhttps://www.psychiatrictimes.com/view/apa-preview-social-worldview-of-psychiatry-and-society<![CDATA[Let's explore the importance of social relationships in psychiatry.]]>Wed, 08 Apr 2026 20:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/bpl-003-for-treatment-resistant-depression-continues-to-show-sustained-symptom-reductionhttps://www.psychiatrictimes.com/view/bpl-003-for-treatment-resistant-depression-continues-to-show-sustained-symptom-reduction<![CDATA[BPL-003 phase 2a part 2 results show reductions in depression symptoms.]]>Wed, 08 Apr 2026 19:48:57 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/first-participants-enrolled-in-phase-2a-study-of-bxcl501-for-treatment-of-acute-stress-reactionshttps://www.psychiatrictimes.com/view/first-participants-enrolled-in-phase-2a-study-of-bxcl501-for-treatment-of-acute-stress-reactions<![CDATA[A new US Department of War backed phase 2a study will test BXCL501's efficacy in easing acute stress reactions and preventing PTSD.]]>Wed, 08 Apr 2026 15:47:30 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/why-arent-we-treating-stroke-as-a-chronic-health-conditionhttps://www.psychiatrictimes.com/view/why-arent-we-treating-stroke-as-a-chronic-health-condition<![CDATA[Stroke recovery lasts years; learn why fatigue, sleep, hormones and cognition demand ongoing rehab beyond 90 days—and how progress can continue.]]>Wed, 08 Apr 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/the-origins-of-pharmacogenomics-with-john-j-miller-mdhttps://www.psychiatrictimes.com/view/the-origins-of-pharmacogenomics-with-john-j-miller-md<![CDATA[Learn more about the history of pharmacogenomics. ]]>Wed, 08 Apr 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/roluperidone-for-negative-symptoms-of-schizophrenia-insights-from-development-expertshttps://www.psychiatrictimes.com/view/roluperidone-for-negative-symptoms-of-schizophrenia-insights-from-development-experts<![CDATA[Experts share how roluperidone provides a new opportunity in the schizophrenia treatment landscape.]]>Wed, 08 Apr 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/different-approaches-for-management-of-treatment-resistant-depressionhttps://www.psychiatrictimes.com/view/different-approaches-for-management-of-treatment-resistant-depression<![CDATA[Why settle for “less bad”? Clinicians urge aggressive depression care aimed at true remission, balancing side effects and patient priorities.]]>Wed, 08 Apr 2026 12:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/evaluating-pitolisant-and-other-pharmacologic-treatment-options-for-narcolepsyhttps://www.psychiatrictimes.com/view/evaluating-pitolisant-and-other-pharmacologic-treatment-options-for-narcolepsy<![CDATA[Explore today’s narcolepsy care: from sleep hygiene to stimulants, oxybates, and pitolisant—targeting sleepiness and cataplexy.]]>Wed, 08 Apr 2026 12:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/targeting-of-glutamatergic-pathway-for-management-of-treatment-resistant-depressionhttps://www.psychiatrictimes.com/view/targeting-of-glutamatergic-pathway-for-management-of-treatment-resistant-depression<![CDATA[Explore glutamate-based depression treatments—esketamine and dextromethorphan-bupropion—boost synaptogenesis and deliver fast relief when monoamines fail.]]>Wed, 08 Apr 2026 12:00:00 GMTPsychiatric TimesusPsychiatric Times Articles